Stage IV Pancreatic Cancer
Oncology
4
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
2
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Monoclonal Antibody
2100%
+ 2 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
GenomicsUK - Oxford
2 programs1
1
NivolumabPhase 2Monoclonal Antibody1 trial
nab-paclitaxelPhase 1/21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GenomicsNivolumab
Genomicsnab-paclitaxel
Mereo BioPharmaOMP-59R5
Clinical Trials (3)
Total enrollment: 63 patients across 3 trials
Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer
Start: Jul 2020Est. completion: Dec 202238 patients
Phase 2Unknown
Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA
Start: May 2013Est. completion: Oct 201725 patients
Phase 1/2Completed
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer
Start: Oct 2012Est. completion: Apr 2016
Phase 1/2Completed
Related Jobs in Oncology
Cell Therapy Account Manager（北陸）
Gilead Sciences
Japan - Tokyo
Just now
Senior Director of Clinical Operations
Arvinas
Remote
1h ago
Specialist, Quality Assurance
Umoja Biopharma
Louisville, Colorado, United States
3h ago
$85K - $105K/yr
Senior Facilities Technician
Umoja Biopharma
Louisville, Colorado, United States
3h ago
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
7h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
9h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space